(Hypertension. 2000;36:33.)
© 2000 American Heart Association, Inc.
Scientific Contributions |
From the Institut für Pharmakologie Universitätsklinikum Essen, Essen, Germany.
Correspondence to Dr Dieter Rosskopf, Institut für Pharmakologie, Universitätsklinikum Essen, Hufelandstr. 55, D-45122 Essen, Germany. E-mail dieter.rosskopf{at}uni-essen.de
| Abstract |
|---|
|
|
|---|
Key Words: hypertension, essential G proteins obesity genetics race
| Introduction |
|---|
|
|
|---|
0.8) and Asians (fT
0.45)8 11 12 compared with whites (fT
0.3).8
GNB3 825T is associated with the occurrence of the splice
variant Gß3s, which, despite a deletion of 41 amino acids, is
functionally active in reconstituted systems.1
Furthermore, there is a strong association among GNB3 825T,
the occurrence of Gß3s, and enhanced signal transduction via
pertussis toxinsensitive G proteins.1 13 This may
cause enhanced vascular reactivity and increased proliferation of
smooth muscle cells and cardiac myocytes, ultimately resulting in
vascular and myocardial hypertrophy. In vivo studies
confirmed this concept and demonstrated an enhanced vascular reactivity
on the stimulation of coronary
2-adrenergic receptors in carriers of
GNB3 825T.14 Likewise, neutrophils from
carriers of GNB3 825T exhibit an increased chemotactic
response.15 16
Gß proteins belong to the superfamily of propeller proteins, and all Gß proteins identified so far consist of 7 WD repeats (referring to the conserved amino acids aspartate and tryptophan) that form a regular torus-like structure.17 18 Gß3s results from alternative splicing of GNB3 and lacks the equivalent of 1 entire WD domain (Figure 1A).1 Because numerous other WD proteins with 4, 5, or 6 WD domains exist,19 a Gß3s structure, as shown in Figure 1B, has been proposed by analogy.1 20 21 In GNB3, the C825T polymorphism is located >1700 bp upstream of the alternative splice site, indicating that the affect of GNB3 825T on the splice process is a complex mechanism. However, such mechanisms have been proposed for other genes.22 23
|
Single nucleotide polymorphisms comparable to GNB3 C825T are found frequently in the human genome,24 and there are numerous examples of originally identified polymorphic markers that are in linkage disequilibrium with subsequently detected causal mutations. The cDNA of GNB3 was originally cloned from human retina,25 and the C825T polymorphism was detected on the study of cell lines from hypertensive subjects with inherited increased signal transduction.1 Ansari-Lari et al26 reported the genomic sequence of GNB3 without describing the promoter or exon/intron structure or reporting additional polymorphisms. In another report, the GNB3 gene structure was described only incompletely.27 Given the obvious involvement of the G protein ß3 subunit in the pathogenesis of obesity/hypertension, an in-depth characterization of its entire gene structure and additional polymorphisms is a prerequisite for an understanding of the molecular mechanisms that contribute to these traits.
The data presented here are the first to describe the promoter region of GNB3, including its regulation by a variety of hormones. Furthermore, we describe the functional organization of GNB3 with regard to exon/intron boundaries. Finally, we report novel polymorphisms in GNB3, their frequencies in different ethnicities, linkage disequilibrium with GNB3 825T, and occurrence in nonhuman primates.
| Methods |
|---|
|
|
|---|
Genotyping Studies in Humans
DNA extraction from blood was performed with the QiaAMP blood
kit (Qiagen) as described.1 PCRs were performed with 4
µL of DNA solution in a final volume of 50 µL with 2.5 U
Taq polymerase and the standard PCR buffer (MBI Fermentas).
Oligonucleotide primers were routinely used at 0.4
µmol/L each, and a 0.2 µmol/L concentration of each dNTP was
added. A first denaturation step of 95°C for 5 minutes was followed
by 35 cycles at 94°C for 1 minute, at 60°C for 45 seconds, and at
72°C for 1 minute. The reaction was completed by a final extension
step at 72°C for 7 minutes. PCR products and the respective
restriction fragments were size-fractionated on 2.5% agarose gels that
contained ethidium bromide and were visualized with UV
transillumination.
C825T Polymorphism
Oligonucleotide primers 5'-TGACCCACTTGCCACCCGTG
C-3' (sense) and 5'-GCAGCAGCCAGGGCTGGC-3' (antisense), encompassing the
genomic sequence from nucleotide (nt) 5348 to 5615, were
used. The numbers of the cDNA sequence and the polymorphisms within
the cDNA [eg, C825T] refer to the original numbering of the
cDNA25 sequence beginning with the translation start codon
ATG=1. Numbers used to describe the gene structure and the
promoter polymorphism (A-350G) refer to the genomic sequence
transcription start site +1. Thus, the ATG of the cDNA
corresponds to nt 1077 of the genomic sequence. Likewise, position 825
of the cDNA corresponds to nt 5500 of the genomic sequence. GenBank
accession numbers for these sequences are U47924, M86525, and U72506.
The GNB3 start codon is located in this latter clone at nt
53298. The C825T polymorphism (genomic localization at nt 5500) was
diagnosed by restriction of the PCR amplicon with BseDI (MBI
Fermentas), resulting in 2 fragments of 115 and 152 bp for the C
allele and in an unrestricted fragment of 267 bp for the T
allele.
G814A Polymorphism
This polymorphism (genomic localization at nt 5489) was
analyzed by digestion with PstI (MBI Fermentas) of
the same PCR amplicon used for the analysis of GNB3
C825T. For the A allele, 2 fragments of 126 and 141 bp were
observed, whereas the amplicon remained unrestricted for the G
allele.
A657T Polymorphism
Oligonucleotide primers 5'-CCATTTTGGCAGTGCCTTGTG
GG-3' (sense) and 5'-ATGTGTTGTGGGGAGTGTCGGG-3' (antisense),
encompassing the genomic sequence from nt 3554 to 3829, were used. The
A657T polymorphism (genomic localization at nt 3725) was diagnosed
by restriction of the PCR amplicon with Eam1105I (MBI
Fermentas), resulting in 2 fragments of 104 and 171 bp for the T
allele and in an unrestricted fragment of 275 bp for the A
allele.
C1429T Polymorphism
Oligonucleotide primers
5'-CAGCCTCTCCCTTAATGAGC-3' (sense) and 5'-ACTACTCTGCTCAGAACTCC-3'
(antisense), encompassing the genomic sequence from nt 6918 to 7527,
were used. The C1429T polymorphism (genomic localization at nt
7087) was diagnosed by restriction of the PCR amplicon with
BshNI (MBI Fermentas), resulting in 3 fragments of 135, 169,
and 305 bp for the C allele and in 2 fragments of 135 and 474 bp
for the T allele.
A(-350)G Polymorphism
Oligonucleotide primers 5'-AGAGGATGGTGGGGTTGG
GAGG-3' (upstream) and
5'-GAGGCTGTGAAAGCAGGG-GTCAG-3'
(downstream), encompassing the promoter region from nt -441 to -79,
were used. The A(-350)G polymorphism was diagnosed by restriction
of the PCR amplicon with TaqI (MBI Fermentas), resulting in
2 fragments of 91 and 270 bp for the G allele and in an
unrestricted fragment of 361 bp for the A allele.
Partial GNB3 Sequences of Nonhuman Primates
DNA of common chimpanzees (Pan troglodytes) and
orangutans (Pongo pygmaeus) was prepared from Epstein-Barr
virusimmortalized lymphoblasts (gift from Dr H. Grosse-Wilde,
European Collection of Biomedical Research, Essen, Germany) with the
column extraction technique (Qiagen). DNA from pygmy/Bonobo chimpanzees
(Pan paniscus) and gorillas (Gorilla gorilla) was
a kind gift of Dr W. Schempp (Freiburg, Germany).
To sequence the alternative splice site region and the C825T polymorphic region in these species, PCR fragments were amplified with the oligonucleotide primers 5'-ACTGT(A/G)T-TTGTGGGACACAC-3' (sense) and 5'-CCGACTC(G/A)TGGCCAGTGA AA-3' (antisense; amplicon nt 532 to 683 of GNB3 cDNA) and the oligonucleotide primers 5'-GAGGCCA-TCTGCACGGGCTC-3' (sense) and 5'-ACGCTCAG(A/C)CTTCATGG AGTC-3' (antisense; nt 715 to 912 of GNB3 cDNA). The sequences encompassing the A(-350)G and the C1429T polymorphisms, respectively, were determined in these species with PCR fragments that were generated with the oligonucleotides indicated for the genotyping studies in humans. PCR fragments were purified with the QIAquick PCR purification kit (Qiagen) and PCR sequenced.
PCR Analysis of GNB3 Structure
For identification of exon/intron boundaries, overlapping
fragments of the GNB3 gene were PCR amplified using human
genomic DNA of 2 white donors (1 individual 825TT, the other 825CC) as
template, and oligonucleotides derived from the Gß3
cDNA. PCR amplicons were purified with spin columns (Qiagen), subcloned
into the pGEM-T vector (Promega), sequenced, and aligned.
Screening of a Human Genomic
PS Library
To characterize the 5'-flanking region of human GNB3,
4x106 phage clones of a genomic library in
PS
(MoBiTec) were lifted in duplicate onto nylon filters (Amersham) and
hybridized to an
-32P-labeled probe derived by
PCR amplification of an intron 3-fragment. Hybridization was performed
in 6x SSC, 5x Denhardts solution, 1% SDS, and 0.1 mg/mL denatured
salmon sperm DNA at 65°C for 24 hours. The filters were washed twice
at room temperature in 2x SSC/0.1% SDS for 30 minutes, once at 60°C
in 0.1x SSC/0.1% SDS for 20 minutes, and exposed to Kodak X-AR film
at -70°C with intensifying screens. Positive clones were further
purified in 3 consecutive rounds, and the resulting phages were used to
infect Escherichia coli strain BNN132
(Cre+) cells to generate plasmid DNA by
translocation that was finally sequenced.
Characterization of the GNB3 Promoter
Generation of Reporter Gene Constructs
Four presumptive promoter fragments containing artificial
KpnI and XhoI sites (underlined here) were
generated with PCR. These fragments extended from a constant 3'-primer
(AP; 5'-CTCGAGGACAGGTCTGCCCCTA TTGTGG-3', ending at nt 21)
and 5'-primers starting at nt -221 (P4, 5'-GGTACCCAC
CTGCTCCCCTCATGCAAATGACC-3'), nt -304 (P3,
5'-GGTACCGCTGGCCTGGGA GGAGACAGG-3'), nt -382 (P2,
5'-GGTACCGGTCGTGA-AGATCTCTCAGCC-3'), or nt -440 (P1,
5'-GGTACCAGAGGATGGTGGGGTTG-GGAGG-3'). PCR amplification
consisted of an initial denaturation at 94°C for 3 minutes, followed
by 35 cycles of 1 minute at 94°C, 45 seconds at 62°C, and 45
seconds at 72°C. Amplicons were agarose gel-purified (QiaEx system,
Qiagen), digested with KpnI and XhoI, ligated
into the corresponding sites of the pSEAP vector (Clontech) upstream of
the reporter gene secretory alkaline phosphatase (SEAP), and sequenced.
The resulting plasmids were transformed into E coli JM109
cells, and vector DNA was prepared using Qiafilter plasmid Maxi kits
(Qiagen).
Transient Transfection in COS-7 Cells
COS-7 cells were routinely maintained in Dulbeccos modified
Eagles medium supplemented with 10% FBS and 100 U/mL penicillin and
100 µg/mL streptomycin (medium constituents from Sigma Chemical Co)
in a 5% CO2 atmosphere at 37°C. Approximately
2x105 COS-7 cells were subcloned onto 6-well
plates, grown to 60% to 70% confluency, and transiently transfected
by lipofection with 4 µg pSEAP-promoter plasmid, complexed with 4
µg DAC30 (Eurogentec), essentially as recommended by the
manufacturer. After transfection, COS-7 cells were cultivated in 1.5 mL
growth medium for 48 hours, detached from the dishes, and pelleted by
centrifugation (12 000g, 20 seconds).
Supernatants were further concentrated with Centricon spin columns
(Amicon). Samples were heated to 65°C for 30 minutes and subsequently
chilled on ice to inactivate residual constitutive alkaline
phosphatase. Thereafter, thermostable SEAP reporter gene activity was
determined with the SEAP reporter system 2 (Clontech) by mixing 150
µL of the supernatant samples with 350 µL of dilution buffer and
500 µL of assay buffer supplied from the test kit. Samples were
thermoequilibrated to room temperature for 5 minutes, the
chemiluminescent substrate CSPD was added to a final concentration of
1.25 mmol/L, and the reaction mixtures were incubated at 37°C
for 10 minutes. The emerging chemiluminescence, which was stable for
60 minutes under these conditions, was determined in a PICA
luminescence aggregometer (Chronolog). Each reporter gene experiment
was performed with COS-7 cells that were transfected in parallel with a
positive control (pSEAP vector containing the SV40 early promoter) and
a baseline control (pSEAP vector harboring the respective Gß3
promoter fragment in inverted orientation). To analyze for
potential GNB3 promoter-activating properties of several
hormones, COS-7 cells were serum-starved beginning 24 hours after
transfection for an additional 24 hours in the presence of the
respective compound. The supernatants were harvested and treated as
described earlier. Serum-depleted COS-7 cells cultivated in the absence
of any agonist served as controls. All experiments were performed in
triplicate.
Bioinformatics
For the prediction of promoter sequences, the TSSW: Recognition
of Human PolII Promoter Region and Start of Transcription
program was used (Gene Finder Program, Baylor College of Medicine;
http://kiwi.imgen.bcm.tmc.edu:8088). Consensus sequences for
transcription factors were sought with the program MatInspector
(www.gsf.de/BIODV/matinspector.html). Haplotype analysis
was conducted with the public domain program EH by Jürg Ott
(http://linkage.rockefeller.edu/ott/eh.htm).
| Results |
|---|
|
|
|---|
PS library. During this study, we became aware
that a huge cosmid clone had already been sequenced and published,
which contained, among several other genes,
GNB3.26 In parallel, a third group
had incompletely characterized the GNB3
gene.27 Figure 1C and Table 1 summarize the results of these
independent studies. Thus, GNB3 is a gene of 7.5 kb that
consists of 11 exons and 10 introns. The sizes of the exons range from
39 to 601 bp, whereas the sizes of introns range from 78 to 1607 bp
(Table 1). All intron/exon splice junctions follow the GT-AG
rule established for eukaryotic genes, with flanking
5'-splice donor and 3'-acceptor sequences closely related to
established consensus sequences.28 Four of the splice
junctions separate codons, whereas the remainder of junctions are
located within codons. The entire exons 1 and 2, as well as the first
30 bp of exon 3, encode the 5'-UTR of the human Gß3 transcript,
whereas the complete 3'-UTR is encoded in exon 11. During this
analysis of the GNB3 structure and its flanking
region, we detected 2 single nucleotide polymorphisms,
A(-350)G and T657A, which were further characterized.
|
Identification and Characterization of the GNB3
Promoter
To define the promoter region of GNB3, we used the
promoter prediction program TSSW and analyzed the 5'-flanking
region GNB3 locus from nt -1720 to 1077 flanking the
transcription start site. One single putative promoter region was
identified at nt -242 (LDF score 5.07). A series of reporter gene
constructs were prepared in which various stretches of this putative
promoter region were ligated upstream of the reporter gene SEAP in the
promoterless pSEAP vector. On expression of the promoterless pSEAP
vector or the pSEAP vectors that contained the inverted GNB3
promoter region in COS-7 cells, SEAP activity was almost absent.
However, on expression of the chimeric pSEAP vectors that harbored the
putative GNB3 promoter region, SEAP activity increased
strongly (Figure 2A). Promoter construct
2 (encompassing nt -381 to 22) most potently increased SEAP activity
by 37±6-fold above basal levels (n=3 independent experiments;
mean±SD; P=0.0005). Truncations of this construct to motifs
encompassing nt -303 to 22 (construct 3) and nt -220 to 22 (construct
4) resulted in 16±2-fold (mean±SD; P=0.0002) and 7±3-fold
(mean±SD; P=0.026) increases in SEAP activity, respectively
(Figure 2A). The longest promoter construct investigated
encompassing nt -440 to 22 (construct 1) exhibited a 26±4-fold
(mean±SD; P=0.0004) increase in SEAP activity and thus was
less potent than construct 2. For comparison, the strong SV40 early
promoter induced a
200-fold increase in SEAP activity.
|
Subsequently, we searched this GNB3 region for transcription
factor consensus binding sites. As shown in Figure 3, the GNB3 promoter region
lacks TATA or CAAT elements, has a 61% G/C content, and contains 1
repeat of the consensus Sp1 binding site. A number of potential
regulatory elements, including activator protein-1
(AP-1), nuclear factor (NF)-
B, interleukin-6 responsive element
(IL6RE), and TCF-binding sites, as well as 5 E-boxes, were found in
the regulatory region of GNB3 (Figure 3). The
presence of these elements suggests that control of Gß3 expression
involves the interactions of various cis-acting elements and
trans-acting factors.
|
Next, we analyzed the inducibility of the GNB3
promoter by reporter gene analysis in COS-7 cells. Treatment
with saturating concentrations of progesterone, estradiol,
testosterone, aldosterone, dexamethasone, cAMP,
L-thyronine, L-thyroxine,
and retinoic acid and exposure to UV light did not significantly affect
SEAP activity. However, treatment with the phorbol ester
12-O-tetradecanoylphorbol-13-acetate
(TPA; 250 nmol/L) increased reporter gene activity from 37±6- to
50±3-fold (P=0.043) above control levels (Figure 2B). This result is in accordance with the presence of consensus
sites for the transcription factors AP-2 and NF-
B in the putative
GNB3 promoter region.
Screening of the GNB3 Gene for Additional
Sequence Variants
GNB3 825T is stringently associated with the expression
of Gß3s, although the alternative splice mechanism is not completely
understood.1 As mentioned, 2 additional
polymorphisms were detected during characterization of the
GNB3 structure and the identification of the promoter
region. In addition, we screened GNB3 for additional
nucleotide variants by sequencing the entire Gß3 cDNA and
the promoter region from several white individuals with different
GNB3 825 alleles. Furthermore, we conducted an extensive
search in the GenBank database. These procedures led to the
identification and characterization of 4 novel GNB3
polymorphisms.
GNB3 G(-350)A Polymorphism
We detected a sequence variance in the promoter region leading to
a G
A substitution at position -350 (Figure 3). In a German
sample of 616 individuals, 37% carried the GG genotype, 48%
carried the AG genotype, and 15% carried the AA
genotype, respectively, which resulted in an allele
frequency fG of 61% (Table 2). The
genotype distribution in the German population was in
accordance with Hardy-Weinberg equilibrium. The functional significance
of the nucleotide exchange is unclear at the present.
In the G allele, the consensus binding motif for an E-box of the
MyoD transcription factor is destroyed. We analyzed
in a reporter gene assay whether this nucleotide exchange
affects GNB3 promoter activity. Reporter gene constructs
corresponding to construct 2 described earlier were generated for both
alleles, sequenced, and expressed in COS-7 cells. Both constructs
exhibited functional promoter activity, but in 3 independent
experiments, we observed no significant differences in SEAP activity
between the 2 allelic constructs (Figure 2C).
|
In black Africans, fG amounted to 76%, and in Chinese individuals, almost all are homozygous carriers of the (-350)G allele (Table 2). Interestingly, all nonhuman primates were homozygous for the G allele, which is, therefore, most likely the ancestral state.
Physically, the GNB3 polymorphisms A(-350)G and C825T
are separated by 5850 bp. Haplotype analysis, however, revealed
a significant linkage disequilibrium between both loci for Africans
(allelic association
2=8.4, 3
parameters, P=0.0384) and Germans (allelic
association
2=58.06, 3 parameters,
P<0.00001). Because of the low frequency of the (-350)A
allele in the Chinese population, a further haplotype
analysis was omitted. For both the African and the German human
samples, the haplotypes GT and AC are significantly favored at the
expense of the haplotypes AT and GC, respectively (Table 3).
|
GNB3 A657T Polymorphism
Next, we identified an A657T polymorphism in GNB3
with a frequency of the 657A allele of 1.4% in the German
population (n=290; Table 2). This A224T exchange is a silent
polymorphism located in the open reading frame of Gß3 that does
not change the amino acid composition of the protein. Allele
frequencies for the 657A allele were 0.5% and 2.4%, respectively,
in black Africans and Chinese. A further haplotype analysis was
not possible due to the low number of 657A allele carriers in these
populations.
GNB3 G814A Polymorphism
This polymorphism leads to a single nucleotide
exchange at position 814 in the cDNA of Gß3, which causes the
replacement of the amino acid glycine at position 272 by serine. Thus,
a highly conserved amino acid motif
(IleIleCysGlyIleThrSerVal) is affected, which connects
the outer strand of the "propeller" blade 5 (domain 5d, according
to Clapham and Neer17 and Sondek et al18 )
with the inner strand of the "propeller" blade 6 (domain 6a) in
Gß3. An identical protein motif is found in Gß1, Gß2, Gß3, and
Gß4.
The frequency of the A allele in the German population amounts to 10% (Table 2). In black Africans and Chinese, GNB3 814A is rare, with allele frequencies of only 2.0% and 0.5%, respectively (Table 2). Haplotype analysis in the German sample indicates a significant association of the 814A allele with the 825C allele (P=0.0041). The G allele is also conserved in nonhuman primates (Figure 4C).
|
GNB3 C1429T Polymorphisms
Finally, we identified a C1429T polymorphism in the distant
3'-UTR of Gß3 that occurs frequently in the German population. This
nucleotide exchange is located 1587 bp downstream of the
C825T polymorphism on GNB3. In an analysis of
362 German individuals, we identified 179 subjects who carried the
1429CC genotype, 146 subjects who carried the 1429TC
genotype, and 37 individuals who carried the 1429TT
genotype. This distribution of genotypes was in
accordance with Hardy-Weinberg equilibrium and resulted in a 1429T
allele frequency of 30% (Table 2). In the African and the
Chinese human samples, we determined 1429T allele frequencies of
38% and 17%, respectively (Table 2). In all populations
investigated, the distribution of genotypes was in accordance
with a model of strong linkage disequilibrium between the
polymorphisms GNB3 C825T and GNB3 C1429T
(Table 4). In the German population,
there is an almost complete association of GNB3 825T with
GNB3 1429T and of GNB3 825C with GNB3
1429C. The haplotypes GNB3 825C1429T and GNB3
825T1429C occur only with very low frequencies (Table 4). A
similar pattern is also observed in the black Africans and Chinese, in
whom the haplotypes GNB3 825T1429T and GNB3
825C1429C occur more frequently than expected. The haplotype
GNB3 825C1429T is almost absent, and in contrast to the
German population, there is a considerable portion of the haplotype
GNB3 825T1429C (Table 4).
|
Finally, we sequenced this region of the GNB3 gene from several nonhuman primates. Interestingly, the GNB3 1429C allele occurred in all of these species, which is, therefore, most likely the ancestral variant (Figure 4).
| Discussion |
|---|
|
|
|---|
Gene Structure of GNB3
The GNB3 gene is located on a gene-rich cluster
of chromosome 12p,26 spanning 7.5 kb and composed of
10 introns and 11 exons of usual sizes. Its gene product, the G
protein subunit Gß3, is a propeller protein that consists of 7
regular WD domains (Figure 1B). Gß3 is the first Gß subunit
for which the gene structure has been elucidated. There is no direct
correlation between WD domains and the exon structure. For example,
exon 6 codes for only 1 ß-strand of a WD domain, whereas exons 9 and
10 define 7 individual ß-strands each. Alternative splicing, which
results in Gß3s, is confined to exon 9, the longest exon in the open
reading frame (Figure 1C).
Identification and Characterization of the GNB3
Promoter
The human Gß3 promoter belongs to the group of promoters without
a TATA box but harbors GC-rich regions. The GC-rich region contains 1
putative binding site for the transcription factor SP1 and 3 putative
binding sites for the transcription factor AP-1 (Figure 3).
Furthermore, consensus sites of NF-
B, NF-1, CBP (CREB-binding
protein), IL6RE, TCF (T-cell factor), and 5 E-boxes were found in a
0.5-kb region that exhibited maximal promoter activity on expression in
COS-7 cells (Figure 3).
Expression of the longest promoter fragment (construct 1) resulted in a
26±4-fold increase in the reporter gene activity (Figure 2A).
Shortening of this fragment (plasmid 2) increased promoter activity to
37±6-fold (Figure 2A). This may indicate the presence of a
silencing element or elements located in this region. However,
extensive computer-aided searches revealed no consensus sequence for
various known transcriptional suppressors within this region. The human
GNB3 promoter activity was not significantly induced by
treatment with aldosterone, dexamethasone,
retinoic acid, testosterone, progesterone, estradiol,
L-thyronine, or cAMP, but it was inducible by the
phorbol ester TPA. Several potential transcription factor binding sites
that could mediate this activation are located within this region; in
particular, the NF-
B site may be responsible for upregulation of
gene expression after TPA treatment. On deletion of this site, the
effect of TPA vanished (construct 4; 7±3-fold in the absence versus
6±2-fold increase in SEAP activity in the presence of TPA; data not
shown).
In addition, we detected a novel polymorphism in the promoter region of GNB3. The substitution of (-350)A by the nucleotide G disrupts the consensus binding sequence for the MyoD transcription factor, which raises the possibility that differences in the transcription levels of Gß3 and Gß3s may contribute to the hypertensive phenotype, especially because a significant linkage disequilibrium exists between the 825 locus and the promoter polymorphism (Table 3). However, expression of reporter gene constructs with the different GNB3 (-350) alleles resulted in almost identical promoter activities (Figure 2C). Furthermore, on Western blot analysis, we did not observe gross differences in Gß3 expression levels between cells harboring the GNB3 825T or 825C allele.1 Nevertheless, future studies that involve the use of more precise methods, including RNase protection assays, will again address the question of whether Gß3 expression levels are influenced by the respective genotypes.
Significance of Additional Polymorphisms in
GNB3
There is strong evidence that the GNB3 825T allele
favors the generation of the splice variant Gß3s, which in turn
causes increased signal transduction and, ultimately, hypertension and
obesity.1 However, the molecular mechanisms involved
have not been elucidated so far. Therefore, we asked whether additional
nucleotide exchanges in linkage disequilibrium with
GNB3 825T may be necessary to cause the alternative splicing
of the gene. As shown in Figure 1, there is a distance of
1700 bp between the alternative splice site and the GNB3
C825T polymorphism. Nevertheless, there are examples that single
distant nucleotide exchanges, not related to conserved
splice branch, donor, and acceptor sites, can cause such alternative
splicing.21 22
In addition to the promoter polymorphism A(-350)G discussed
earlier, we characterized 3 additional polymorphisms in
GNB3. Two of them, GNB3 A657T and GNB3
G814A, occur at low frequencies in the 3 populations investigated so
far (Table 2). Interestingly, GNB3 G814A leads to an
amino acid exchange at a highly conserved protein motif in Gß
proteins. At the present, we have no evidence of any biochemical
significance of this amino acid substitution. Expression and functional
analysis of this Gß3 variant are required to understand
whether it affects Gß3 processing, its interaction with G
and G
proteins, and, ultimately, the effect of such a Gß3
dimer on
interaction with receptors and effectors. Because this allele
occurs at a frequency of
10% in the white population and it is
strongly associated with GNB3 825C, association studies with
hypertension, obesity, or both are required in the future.
The GNB3 1429T allele occurs with high frequencies in whites, black Africans, and Asians (Table 2). It is located in the 3'-UTR of the Gß3 mRNA and in tight linkage disequilibrium to the GNB3 825T allele. Thus, in whites, there is such a strong linkage disequilibrium between these loci at positions 825 and 1429 that in praxi we observed only 2 haplotypes: GNB3 825C1429C and GNB3 825T1429T. This leads to the question of whether GNB3 1429T is necessary (together with GNB3 825T) or possibly sufficient (without GNB3 825T) for the generation of Gß3s. It is possible that a concerted action of GNB3 825T and GNB3 1429T is required, to favor an hnRNA structure necessary for the splicing of the Gß3s gene product. Because our preceding studies on the association of GNB3 825T with the expression of Gß3s and essential hypertension included only German subjects,1 we cannot answer this question at the present. Quantification of Gß3s transcripts and the analysis of Gß3s protein levels in different ethnic groups will help to resolve the question of how these haplotypes may affect alternative splicing of GNB3.
In nonwhites, the frequency of the GNB3 1429T allele is significantly lower than that of GNB3 825T. In these populations, the haplotypes GNB3 825C1429C, 825T1429C, and 825T1429T occur frequently, whereas the haplotype 825C1429T is rare. Several independent studies have confirmed the association of GNB3 825T with essential hypertension in whites1 4 5 6 and blacks7 ; however, in Asian and American Indian populations, the association of GNB3 825T with hypertension was absent11 or complex.12 It is possible that a certain genetic or ethnic background is necessary for the expression of the hypertensive phenotype in carriers of GNB3 825T. Hence, detailed epidemiological studies in nonwhite populations for both GNB3 825T and GNB3 1429T and their potential interaction with hypertension are necessary to resolve this issue. Although this question is open for hypertension, the presence of GNB3 825T appears sufficient for an increased risk of overweight in all populations investigated so far.8 9 10
Finally, we characterized the GNB3 polymorphisms and the sequence motifs decisive for the splicing of Gß3s in nonhuman primates (Figure 4). In all species, the sequence motifs necessary for the alternative splicing leading to Gß3s (ie, the alternative branch and acceptor sites) are conserved. However, at loci GNB3 825 and GNB3 1429, the C alleles are present, suggesting that the C is the ancestral state at these positions. Therefore, it is likely that the mutation from C to T at these positions occurred since the split from humans and chimpanzees 5 million years ago.
In conclusion, we have presented the organization of the GNB3 gene, and we characterized its promoter. This and the identification of additional polymorphisms will enable the future analysis of the processes that generate the splice variant Gß3s. The combined analysis of the novel single nucleotide exchanges with respect to hypertension and obesity in different ethnic groups could help to provide an understanding of the scenario in which GNB3 825T in concert with the other variants influences the observed variation in blood pressure and body weight. This could ultimately lead to an enhanced precision in the prediction of the risk for hypertension and obesity in individuals with these nucleotide exchanges in GNB3.
| Acknowledgments |
|---|
Received January 26, 2000; first decision February 4, 2000; accepted February 9, 2000.
| References |
|---|
|
|
|---|
2. Neer EJ. Heterotrimeric G proteins: organizers of transmembrane signals. Cell. 1995;80:249257.[Medline] [Order article via Infotrieve]
3.
Hamm HE. The many faces of G protein signaling.
J Biol Chem. 1998;273:669672.
4.
Schunkert H, Hense H-W, Döring A, Riegger GA,
Siffert W. Association between a polymorphism in the G protein
ß3-subunit gene and lower renin and elevated diastolic
blood pressure levels. Hypertension. 1998;32:510513.
5.
Benjafield AV, Jeyasingam CL, Nyholt DR, Griffiths LR,
Morris BJ. G-protein ß3 subunit gene (GNB3) variant
in causation of essential hypertension. Hypertension. 1998;32:10941097.
6.
Beige J, Hohenbleicher H, Distler A, Sharma AY.
G-protein ß3 subunit C825T variant and ambulatory blood pressure
in essential hypertension. Hypertension. 1999;33:10491051.
7.
Dong Y, Zhu H, Sagnella GA, Carter ND, Cook DG,
Cappuccio FP. Association between the C825T polymorphism of the G
protein ß3-subunit gene and hypertension in blacks.
Hypertension. 1999;34:11931196.
8.
Siffert W, Forster P, Jöckel K-H, Mvere DA,
Brinkmann B, Naber C, Crookes R, Heyns AdP, Epplen JT, Fridey J,
Freedman BI, Müller N, Stolke D, Sharma AM, al Moutaery K,
Grosse-Wilde H, Buerbaum B, Ehrlich T, Ahmad HR, Horsthemke B, du Toit
ED, Tilikainen A, Ge J, Wang Y, Yang D, Hüsing D, Rosskopf D.
Worldwide ethnic distribution of the G protein ß3 subunit 825T
allele and its association with obesity in Caucasians, Chinese, and
black African individuals. J Am Soc Nephrol. 1999;10:19211930.
9. Siffert W, Naber C, Walla M, Ritz E. G protein ß3 subunit 825T allele and its potential association with obesity in hypertensive individuals. J Hypertens. 1999;17:14.[Medline] [Order article via Infotrieve]
10.
Hegele RA, Anderson C, Young TK, Connelly PW.
G-protein ß3 subunit gene splice variant and body fat
distribution in Nunavut Inuit. Genome Res. 1999;9:972977.
11.
Kato N, Sugiyama T, Morito H, Kurihara H, Yamori Y,
Yazaki Y. G protein ß3 subunit variant and essential
hypertension in Japanese. Hypertension. 1998;32:935938.
12.
Hegele, RA, Harris SB, Hanley AJG, Cao H, Zinman B. G
protein ß3 subunit gene variant and blood pressure variation in
Canadian Oji-Cree. Hypertension. 1998;32:688692.
13. Siffert W, Rosskopf D, Moritz A, Wieland T, Kaldenberg-Stasch S, Kettler N, Hartung K, Beckmann S, Jakobs KH. Enhanced G protein activation in immortalized lymphoblasts from patients with essential hypertension. J Clin Invest. 1995;96:759766.
14.
Baumgart D, Naber C, Haude M, Oldenburg O, Erbel R,
Heusch G, Siffert W. G protein ß3 subunit 825T allele and
enhanced coronary vasoconstriction on
2-adrenoceptor activation. Circ
Res. 1999;85:965969.
15. Virchow S, Ansorge N, Rübben H, Siffert G, Siffert W. Enhanced fMLP-stimulated chemotaxis in human neutrophils from individuals carrying the G protein ß3 subunit 825 T allele. FEBS Lett. 1998;436:155158.[Medline] [Order article via Infotrieve]
16. Virchow S, Ansorge N, Rosskopf D, Rübben H, Siffert W. The G protein ß3 subunit splice variant Gß3-s causes enhanced chemotaxis of human neutrophils in response to interleukin-8. Naunyn-Schmiedebergs Arch Pharmacol. 1999;369:2732.
17.
Clapham DE, Neer EJ. G protein ß
subunits.
Annu Rev Pharmacol Toxicol. 1997;37:167203.[Medline]
[Order article via Infotrieve]
18.
Sondek J, Bohm A, Lambright DG, Hamm HE, Sigler PB.
Crystal structure of a GA protein ß
dimer at
2.1 Å resolution. Nature. 1996;379:369374.[Medline]
[Order article via Infotrieve]
19. Neer EJ, Schmidt CJ, Nambudripad R, Smith TF. The ancient regulatory protein family of WD-repeat proteins. Nature. 1994;371:297300.[Medline] [Order article via Infotrieve]
20. Iiri T, Bourne HR. G proteins propel surprise. Nat Genet. 1998;18:810.[Medline] [Order article via Infotrieve]
21. Iiri T, Farfel Z, Bourne HR. G-protein diseases furnish a model for the turn-on switch. Nature. 1998;394:3538.[Medline] [Order article via Infotrieve]
22.
Stallings-Mann ML, Ludwiczak RL, Klinger KW, Rottman F.
Alternative splicing of exon 3 on the human growth hormone receptor is
the result of an unusual genetic polymorphism. Proc Natl Acad
Sci U S A. 1996;93:1239412399.
23. Liu W, Qian C, Francke U. Silent mutation induces exon skipping of fibrillin-1 gene in Marfan syndrome. Nat Genet. 1997;16:328329.[Medline] [Order article via Infotrieve]
24. Halushka MK, Fan J-B, Bentley K, Hsie L, Shen N, Weder A, Cooper R, Lipshutz R, Chakravarti A. Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis. Nat Genet. 1999;22:239247.[Medline] [Order article via Infotrieve]
25. Levine MA, Smallwood PM, Moen PT Jr, Helman LJ, Ahn TG. Molecular cloning of ß3 subunit, a third form of the G protein ß-subunit polypeptide. Proc Natl Acad Sci U S A. 1990;80:23292333.
26.
Ansari-Lari MA, Muzny DM, Lu J, Lu F, Lilley CE, Spanos
S, Malley T, Gibbs RA. A gene-rich cluster between CD4 and
triosephosphate isomerase genes at human chromosome 12p13. Genome
Res. 1996;6:314326.
27.
Gao YQ, Danciger M, Akhmedov NB, Zhao DY, Heckenlively
JR, Fishman GA, Weleber RG, Jacobson SG, Farber DB. Exon screening of
the genes encoding the ß- and
-subunits of cone transducin in
patients with inherited retinal diseases. Mol Vision. 1998;4:1620.[Medline]
[Order article via Infotrieve]
28. Lewin B. Nuclear splicing. In: Lewin B. Genes. New York. NY: Oxford University Press; 1997:885913.
This article has been cited by other articles:
![]() |
N. Eynon, J. Oliveira, Y. Meckel, M. Sagiv, C. Yamin, M. Sagiv, R. Amir, and J. A. Duarte The guanine nucleotide binding protein \#946; polypeptide 3 gene C825T polymorphism is associated with elite endurance athletes Exp Physiol, March 1, 2009; 94(3): 344 - 349. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Lelonek, T. Pietrucha, M. Matyjaszczyk, and J. H. Goch A novel approach to syncopal patients: association analysis of polymorphisms in G-protein genes and tilt outcome Europace, January 1, 2009; 11(1): 89 - 93. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. van der Net, J. van Etten, M. Yazdanpanah, G. M. Dallinga-Thie, J. J.P. Kastelein, J. C. Defesche, R. P. Koopmans, E. W. Steyerberg, and E. J.G. Sijbrands Gene-load score of the renin-angiotensin-aldosterone system is associated with coronary heart disease in familial hypercholesterolaemia Eur. Heart J., June 1, 2008; 29(11): 1370 - 1376. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Siffert Effects of the G protein {beta}3-subunit gene C825T polymorphism: should hypotheses regarding the molecular mechanisms underlying enhanced G protein activation be revised? Focus on "A splice variant of the G protein {beta}3-subunit implicated in disease states does not modulate ion channels" Physiol Genomics, April 16, 2003; 13(2): 81 - 84. [Full Text] [PDF] |
||||
![]() |
V. Ruiz-Velasco and S. R. Ikeda A splice variant of the G protein {beta}3-subunit implicated in disease states does not modulate ion channels Physiol Genomics, April 16, 2003; 13(2): 85 - 95. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Heusch, R. Erbel, and W. Siffert Genetic determinants of coronary vasomotor tone in humans Am J Physiol Heart Circ Physiol, October 1, 2001; 281(4): H1465 - H1468. [Full Text] [PDF] |
||||
![]() |
S. T. Turner, G. L. Schwartz, A. B. Chapman, and E. Boerwinkle C825T Polymorphism of the G Protein {beta}3-Subunit and Antihypertensive Response to a Thiazide Diuretic Hypertension, February 1, 2001; 37(2): 739 - 743. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |